SCHEMBL4859960

SCHEMBL4859960

CCOC(=O)N1CCN(c2ccccc2C2CCC(C)(C)CC2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
MAPT P10636 8/20 0.54
ALDH1A1 P00352 4/20 0.54
LMNA P02545 3/20 0.46
TSHR P16473 2/20 0.46
MAPK1 P28482 2/20 0.46
HSD17B10 Q99714 2/20 0.46
NPC1 O15118 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 1/20 0.45
PKM P14618 1/20 0.45
HTT P42858 1/20 0.44
BRD4 O60885 1/20 0.44
ALOX12 P18054 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
NOS2 P35228 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4258536 0.86 GPR119 (0.49) MAPTALDH1A1LMNA
SCHEMBL4852456 0.84 GAA (0.58) GAASMN1; SMN2MAPTALDH1A1LMNA
SCHEMBL4859730 0.84 MAPT (0.47) MAPTALDH1A1LMNATSHRNPC1
SCHEMBL4256470 0.79 HTR1A (0.45) GAAMAPTALDH1A1LMNATSHR
SCHEMBL4251027 0.79 GPR119 (0.46) GAASMN1; SMN2MAPTLMNAKDM4E
Hydrochloric Acid SCHEMBL4859688 0.78 HTR1A (0.44) GAAMAPTALDH1A1LMNATSHR
SCHEMBL27671027 0.76 HTR1A (0.42) GAASMN1; SMN2MAPTALDH1A1LMNA
Hydrochloric Acid SCHEMBL4854257 0.76 HTR1A (0.51) LMNAKDM4E
SCHEMBL3436308 0.76 MAPT (0.78) GAASMN1; SMN2MAPTALDH1A1LMNA
SCHEMBL14064640 0.75 KDM4E (0.53) LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1698620-B1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS EISAI R&D MAN CO LTD (JP) 2016-09-28 EP disclosed
US-7425554-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-09-16 US disclosed
US-7410971-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-08-12 US disclosed
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-17 US disclosed
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-12-07 US disclosed
EP-1698620-A1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS Eisai Co., Ltd. (JP) 2006-09-06 EP disclosed
US-20050261291-A1 1,2-Di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds CCR10, HRH3, HRH1 GAA 4860/4885SMN1; SMN2 2729/4885MAPT 2411/4885
US-20050261291-A1 1,2-Di(cyclic)substituted benzene compounds CCR10, HRH3, HRH2 GAA 4874/4885SMN1; SMN2 2692/4885MAPT 2870/4885
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds HRH3, CCR10, HRH1 GAA 4880/4885SMN1; SMN2 1754/4885MAPT 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.